Ecstasy-Induced Malignant Hyperthermia with Fatal Outcome: A Case Report

1. Meyer JS. 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Subst Abuse Rehabil 2013; 4: 83-89.10.2147/SAR.S37258393169224648791Search in Google Scholar

2. Armenian P et al. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. J Intensive Care Med 2012; 28 (4): 252-258.10.1177/088506661244598222640978Search in Google Scholar

3. Hall AP, Henry JA. Acute toxic effects of “Ecstasy” (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 2006; 96 (6): 678-685.10.1093/bja/ael07816595612Search in Google Scholar

4. Connolly E, O´Callaghan G. MDMA toxicity presenting with severe hyperpyrexia: a case report. Crit Care Resusc 1999; 1: 368-370.Search in Google Scholar

5. Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ 2001; 165 (7): 917-928.Search in Google Scholar

6. Baselt, RC. Disposition of toxic drugs and chemicals in man. Tenth Edition. California: Biomedical Publications; 2014.Search in Google Scholar

7. Fiege M etal. Induction of malignant hyperthermia in susceptible swine by 3,4- Methylenedioxy-methamphetamine (“Ecstasy”). Anesthesiology 2003; 99 (5):1132-1136.10.1097/00000542-200311000-0002014576550Search in Google Scholar

8. Green AR et al. The pharmacology and clinical pharmacology of 3,4-methyledioxymethampheta-mine (MDMA, “Ecstasy”). Pharmacol Rev 2003; 55: 463-508.10.1124/pr.55.3.312869661Search in Google Scholar

9. Passie T et al. Ecstasy (MDMA) mimics the post-orgasmic state:impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion. Med Hypotheses 2005; 64: 899-903.10.1016/j.mehy.2004.11.04415780482Search in Google Scholar

10. Lang et al. Fatal Ecstasy-induced malignant hyperthermia with rhabdomyolysis. A case report. Rom J Leg Med 2016; 24: 212-215.10.4323/rjlm.2016.212Search in Google Scholar

11. Manish et al. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. J Emerg Med 2005; 29 (4): 451-454.10.1016/j.jemermed.2005.05.00716243206Search in Google Scholar

12. Národná kriminálna agentúra (NAKA), Národná protidrogová jednotka, Prezídium Policajného zboru SR, Ministerstvo vnútra SR. Správa o stave a vývoji drogovej scény na území Slovenskej republiky v roku 2017. Bratislava; 2018.Search in Google Scholar